Skip to main content
SpringerLink
Log in

Menopause in Autoimmune Disease and Hormone Replacement Therapy

  • Chapter
  • First Online:
Women's Health in Autoimmune Diseases

  • 459 Accesses

Abstract

The relationship between autoimmune diseases and menopause is complex. While deleterious effects of menopause on cardiovascular, genitourinary, skeletal, and central nervous systems due to deficiency of gonadal hormones can contribute to morbidity in autoimmune diseases, autoimmune diseases as well as their treatment per se can accelerate or predate development of menopause. Furthermore, diagnosis of autoimmune disorders may be difficult in the setting of menopause due to overlapping signs and symptoms. In this chapter we discuss the complex relationship between menopause and common autoimmune diseases. We also discuss the effects of menopause on common autoimmune diseases and vice versa and also menopausal hormone therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ahuja M (2016) Age of menopause and determinants of menopause age: a PAN India survey by IMS. J Midlife Health 7(3):126–131

    PubMed  PubMed Central  Google Scholar 

  2. Bansal R, Aggarwal N (2019) Menopausal hot flashes: a concise review. J Midlife Health 10:6–13

    PubMed  PubMed Central  Google Scholar 

  3. Sammaritano LR (2012) Menopause in women with autoimmune diseases. Autoimmun Rev 11:A430–A436

    Article  PubMed  Google Scholar 

  4. Bultink IEM, Lems WF, Kostense PJ, Dijkmans BAC, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 527:2044–2050

    Article  Google Scholar 

  5. Sharma S, Tandon VR, Mahajan A (2007) Menopausal symptoms in urban women. JK Sci 9(1):13–17

    Google Scholar 

  6. Lund KJ (2008) Menopause and the menopausal transition. Med Clin North Am 92:1253–1271

    Article  PubMed  Google Scholar 

  7. Lubo RA (2007) Menopause: endocrinology, consequences of estrogen deficiency, effects of hormone replacement therapy, treatment regimens. In: Katz VL, Lentz GM, Lobo RA, Gershenson DM (eds) Comprehensive gynecology, 5th edn. Mosby Elsevier, Philadelphia, PA, pp 1039–1071

    Chapter  Google Scholar 

  8. Stokes J III, Kannel WB, Wolf PA, Cupples LA, D’Agostino RB (1987) The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 75(6):V65–V73

    PubMed  Google Scholar 

  9. Desai MK, Brinton RZ (2019) Autoimmune diseases in women: endocrine transition and risk across the life span. Front Endocrinol 10:265

    Article  Google Scholar 

  10. Arteni A, Fabiani G, Marchesoni D (2014) Hormone replacement therapy and autoimmune diseases. Giorn It Ost Gin 36(2):322–327

    Google Scholar 

  11. Ebrahimi M, Akbari Asbagh F (2011) Pathogenesis and causes of premature ovarian failure: an update. Int J Fertil Steril 5:54–65

    PubMed  PubMed Central  Google Scholar 

  12. Forges T, Monnier-Barbarino P, Faure GC, Bene MC (2004) Autoimmunity and antigenic targets in ovarian pathology. Hum Reprod Update 10:163–175

    Article  CAS  PubMed  Google Scholar 

  13. Ebrahimi M, Akbari Asbagh F (2015) The role of autoimmunity in premature ovarian failure. Iran J Reprod Med 13(8):461–472

    PubMed  PubMed Central  Google Scholar 

  14. Vallotton MB, Forbes AP (1996) Antibodies to cytoplasm of ova. Lancet 2:264–265

    Google Scholar 

  15. Reato G, Morlin L, Chen S, Furmaniak J, Smith BR, Masiero S et al (2011) Premature ovarian failure in patients with autoimmune Addison’s disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab 96:1255–1261

    Article  CAS  Google Scholar 

  16. Takamizawa S, Shibahara H, Shibayama T, Suzuki M (2007) Detection of antizona pellucida antibodies in the sera from premature ovarian failure patients by a highly specific test. Fertil Steril 88:925–932

    Article  PubMed  Google Scholar 

  17. Kinoshita A, Tanaka H, Komori S, Hasegawa A, Koyoma K (2006) Autoimmunity to zona pellucida possibly causes premature ovarian failure (POF). J Reprod Immunol 71:155

    Article  Google Scholar 

  18. Khole V (2010) Does ovarian autoimmunity play a role in the pathophysiology of premature ovarian insufficiency? J Midlife Health 1:9–13

    PubMed  PubMed Central  Google Scholar 

  19. Lebovic DI, Naz R (2004) Premature ovarian failure: think “autoimmune disorder”. Sex Reprod Menopause 2:230–233

    Article  Google Scholar 

  20. Massin N, Gougeon A, Meduri G, Thibaud E, Laborde K, Matuchansky C et al (2004) Significance of ovarian histology in the management of patients presenting a premature ovarian failure. Hum Reprod 19:2555–2560

    Article  CAS  PubMed  Google Scholar 

  21. Lass A (2001) Assessment of ovarian reserve—is there a role for ovarian biopsy? Hum Reprod 16:1055–1057

    Article  CAS  PubMed  Google Scholar 

  22. Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S et al (2005) Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46, XX spontaneous premature ovarian failure. Fertil Steril 84:958–965

    Article  PubMed  Google Scholar 

  23. Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364

    Article  CAS  PubMed  Google Scholar 

  24. Horejesi J, Martinek J, Novakova D, Madar J, Brandejska M (2000) Autoimmune antiovarian antibodies and their impact on the success of an IVF/ET program. Ann N Y Acad Sci 900:351–356

    Article  Google Scholar 

  25. Forges T, Monnier-Barbarino P, Guillet-May F, Faure GC, Bene MC (2006) Corticosteroids in patients with antiovarian antibodies undergoing in vitro fertilization: a prospective pilot study. Eur J Clin Pharmacol 62:699–705

    Article  CAS  PubMed  Google Scholar 

  26. Edassery SL, Shatavi SV, Kunkel JP, Ch H, Brucker C, Penumatsa K et al (2010) Autoantigens in ovarian autoimmunity associated with unexplained infertility and premature ovarian failure. Fertil Steril 94:2636–2641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mok CC, Lau CS, Wong RWS (1998) Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 41(5):831–837

    Article  CAS  PubMed  Google Scholar 

  28. Katsifis GE, Tzioufas AG (2004) Ovarian failure in systemic lupus erythematosus patients with pulsed intravenous cyclophosphamide. Lupus 13:673–678

    Article  CAS  PubMed  Google Scholar 

  29. Ho CTK, Mok CC, Lau CS, Wong RWS (1998) Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis 57:437–440

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Cutolo M, Capelino S, Sulli A, Serioli B, Secchi M, Villaggio B et al (2006) Estrogens and autoimmune diseases. Ann N Y Acad Sci 1089:538–547

    Article  CAS  PubMed  Google Scholar 

  31. Font J, Pallares L, Cervera R, Lopez-Soto A, Navarro M, Bosch X et al (1991) Systemic lupus onset in the elderly: clinical and immunological characteristics. Ann Rheum Dis 50:702–705

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Boddaert J, Huong DLT, Amoura Z, Wechlser B, Godeau P, Piette JC (2004) Late onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine 83(6):348–359

    Article  PubMed  Google Scholar 

  33. Urowitz MB, Ibanez D, Jerome D, Gladman DD (2006) The effect of menopause on disease activity in systemic lupus erythematosus. J Rheumatol 33:2192–2198

    PubMed  Google Scholar 

  34. Talsania M, Scofield RH (2017) Menopause and rheumatic disease. Rheum Dis Clin N Am 43(2):287–302

    Article  Google Scholar 

  35. Sanchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA (1995) Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 122(6):430–433

    Article  CAS  PubMed  Google Scholar 

  36. Fernandez M, Calvo-Alen J, Alarcon G, Roseman JM, Bastian HM, Fessler BJ et al (2005) Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXI. Disease activity, damage accrual and vascular events in pre- and post-menopausal women. Arthritis Rheum 52(6):1655–1664

    Article  PubMed  Google Scholar 

  37. Gonzalez LA, Pons-Estel GJ, Zhang JS, McGwin G, Roseman J, Reveille JD et al (2009) Effect of age, menopause and cyclophosphamide use on damage accrual in SLE patients from LUMINA, a multiethnic lupus cohort (LUMINA LXIII). Lupus 18:184–186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Ostenson M, Aune B, Husby G (1983) Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 12(2):69–72

    Article  Google Scholar 

  39. Silman A, Kay A, Brennan P (1992) Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 35(2):152–155

    Article  CAS  PubMed  Google Scholar 

  40. Spector TD, Roman E, Silman AJ (1990) The pill, parity and rheumatoid arthritis. Arthritis Rheum 33(6):782–789

    Article  CAS  PubMed  Google Scholar 

  41. Karlson EW, Mandl LA, Hankinson SE, Grodstein F (2004) Do breastfeeding and other reproductive factors influence future risk of rheumatoid arthritis: results from the Nurses’ Health Study. Arthritis Rheum 50(11):3458–3467

    Article  PubMed  Google Scholar 

  42. Merlino CJR, Criswell LA, Mikuls TR, Saag KG (2003) Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women. Semin Arthritis Rheum 33(2):72–82

    Article  CAS  PubMed  Google Scholar 

  43. Pikwer M, Bergstrom U, Nilsson J-A, Jacobsson L, Turesson C (2012) Early menopause is a independent predictor of rheumatoid arthritis. Ann Rheum Dis 71(3):378–381

    Article  PubMed  Google Scholar 

  44. Kuiper SA, van Gestel AM, Swinkels HL, de Boo TM, da Silva JAP, van Riel PLCM (2001) Influence of sex, age, and menopausal status on the course of early rheumatoid arthritis. J Rheumatol 28:1809–1816

    CAS  PubMed  Google Scholar 

  45. Walitt B, Pettinger M, Weinstein A, Katz J, Torner J, Wasko MC, Howard BV (2008) Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women’s health initiative randomized controlled trials. Arthritis Rheum 59:302–310

    Article  PubMed  PubMed Central  Google Scholar 

  46. Bove R (2013) Autoimmune disease and reproductive aging. Clin Immunol 149(2):251–264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Marder W, Vinet E, Somers EC (2015) Rheumatic autoimmune diseases in women and midlife health. Women’s Midlife Health 1:11

    Article  PubMed  PubMed Central  Google Scholar 

  48. Scorza R, Caronni M, Bazzi S, Nador F, Beretta L, Antonioli R et al (2002) Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis. Ann N Y Acad Sci 966:238–246

    Article  PubMed  Google Scholar 

  49. Beretta L, Caronni M, Origgi L, Ponti A, Santaniello A, Scorza R (2006) Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Scand J Rheumatol 35(6):468–471

    Article  CAS  PubMed  Google Scholar 

  50. Larsson K, Mellstrom D, Nordborg E, Oden A, Nordborg E (2006) Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis. Ann Rheum Dis 65(4):529–532

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, Post Graduate Institute of Medical Education and Research, Chandigarh, India

    Ramandeep Bansal & Neelam Aggarwal

Authors
  1. Ramandeep Bansal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neelam Aggarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine, PGIMER, Chandigarh, India

    Shefali Khanna Sharma

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bansal, R., Aggarwal, N. (2020). Menopause in Autoimmune Disease and Hormone Replacement Therapy. In: Sharma, S. (eds) Women's Health in Autoimmune Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-15-0114-2_25

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-0114-2_25

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-0113-5

  • Online ISBN: 978-981-15-0114-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation